A Nature Metabolism study identifies fructose as a key driver of obesity and metabolic syndrome. By bypassing energy controls ...

The Drugs Consultative Committee (DCC), during its 68th meeting, deliberated on strengthening regulatory oversight and enforcement against surrogate advertising of ...

The UAE has approved Foundayo (orforglipron), Eli Lilly's once-daily oral obesity pill, becoming one of the first countries ...

The U.S. Food and Drug Administration approved the pill for weight loss earlier this month, intensifying Lilly's competition ...

Discover the top 10 weight loss medications of 2026. Explore how advanced GLP-1 therapies and combination drugs are reshaping ...

A global study reveals a sharp rise in metabolic syndrome prevalence from 2000 to 2023, highlighting urgent public health ...

Obesity trials are evolving toward chronic disease models with improved endpoints, longer study designs, and greater clinical ...

A new study suggests an alternative to BMI for assessing heart failure risk, showing that fat location matters more than ...

Battling concerns that a third of the Indian population will become obese by 2050, the Central Drugs Standard Organisation ...

For the past three years, nearly every breakthrough in obesity medicine has traced back to a single class of drugs: GLP-1 ...

Foods high in protein and fiber are better at holding off hunger—that can include eggs, fatty fish, oatmeal, and more.